Table 1 Patient characteristics.
| Baseline | At time of switch to sorafenib | |
|---|---|---|
| Number of patients | 15 | 9 |
| Median age (range) in yrs | 58 (39-80) | |
| Gender, n | ||
| Male | 11 | |
| Female | 4 | |
| ECOG Performance status, n | ||
| 0-1 | 7 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 0 | |
| Previous nephrectomy, n | 14 | |
| No. of disease sites, n | ||
| 1 | 0 | |
| 2 | 10 | |
| > = 3 | 45 | |
| Metastatic sites, n | ||
| Lung | 7 | |
| Lymph nodes | 3 | |
| Bone | 4 | |
| Peritoneum | 4 | |
| Pancreas | 1 | |
| Liver | 5 | |
| CNS | 1 |